- Home
- SQFT vs CYCN Comparison
SQFT vs CYCN Comparison
Compare SQFT & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQFT
- CYCN
- Stock Information
- Founded
- SQFT 1999
- CYCN 2018
- Country
- SQFT United States
- CYCN United States
- Employees
- SQFT N/A
- CYCN N/A
- Industry
- SQFT Real Estate Investment Trusts
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- SQFT Real Estate
- CYCN Health Care
- Exchange
- SQFT Nasdaq
- CYCN Nasdaq
- Market Cap
- SQFT 6.2M
- CYCN 6.5M
- IPO Year
- SQFT 2020
- CYCN N/A
- Fundamental
- Price
- SQFT $9.07
- CYCN $3.18
- Analyst Decision
- SQFT
- CYCN
- Analyst Count
- SQFT 0
- CYCN 0
- Target Price
- SQFT N/A
- CYCN N/A
- AVG Volume (30 Days)
- SQFT 2.6M
- CYCN 33.4K
- Earning Date
- SQFT 08-13-2025
- CYCN 08-06-2025
- Dividend Yield
- SQFT N/A
- CYCN N/A
- EPS Growth
- SQFT N/A
- CYCN N/A
- EPS
- SQFT N/A
- CYCN N/A
- Revenue
- SQFT $18,260,398.00
- CYCN $2,081,000.00
- Revenue This Year
- SQFT $23.63
- CYCN N/A
- Revenue Next Year
- SQFT N/A
- CYCN N/A
- P/E Ratio
- SQFT N/A
- CYCN N/A
- Revenue Growth
- SQFT N/A
- CYCN N/A
- 52 Week Low
- SQFT $4.19
- CYCN $1.27
- 52 Week High
- SQFT $23.00
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- SQFT 61.65
- CYCN 50.04
- Support Level
- SQFT $4.55
- CYCN $2.95
- Resistance Level
- SQFT $23.00
- CYCN $3.74
- Average True Range (ATR)
- SQFT 1.43
- CYCN 0.34
- MACD
- SQFT 0.64
- CYCN 0.02
- Stochastic Oscillator
- SQFT 25.56
- CYCN 45.63
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.